Commenting today on the Centers for Medicare & Medicaid Services’ proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2020, AHA said it generally supports the reforms to update the payment system, but expressed concern with the substantial redistribution of cases under the payment model proposed for FY 2020. The comment letter raises concerns regarding the FY 2020 case-mix system reforms finalized in last year’s rulemaking, as well as proposed changes to quality outcomes reporting and patient assessments. “[W]e remain concerned that these new policies are, in part, based on unreliable data and that the proposed rule lacks adequate detail and transparency,” AHA wrote. “We also are concerned that the proposed rule lacks the patient-level and cost data needed to replicate the model for the purpose of evaluating its impact to consider whether alternatives would be warranted. These issues deserve further discussion and transparency in the final rule to allow the field to best prepare for the changes and serve their patients.”

Headline
The AHA Aug. 5 provided comments to the Centers for Medicare & Medicaid Services on the distribution of funding for the Rural Health Transformation…
Headline
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future…
Headline
A blog by Shannon Wu, AHA director of payment policy, explains why having access to care close to home and the existence of rural hospitals are fundamental…
Blog
Public
Healthcare affordability discussions often focus on premiums, deductibles and drug prices. Those costs matter. But for the more than 46 million Americans who…
Headline
The Senate is expected to vote this week on its own continuing resolution to fund the federal government through Dec. 11. The chamber, scheduled to leave for…
Headline
The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers…